CVS Analyst Day This Friday, 10/8


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


JP Morgan has published a research report for CVS Caremark Corporation (NYSE: CVS) in anticipation of the company's Analyst Day this Friday, October 8.In the report, JP Morgan writes "We don't believe the Walgreen Company (NYSE: WAG) dispute materially impacted the selling season, and that the company could report $1 billion in 2011 net new business. We look for incremental commentary on the Aetna (NYSE: AET) agreement, which we believe served as a key validator of the integrated model. In addition, we expect the company to focus on its strong clinical offering, as well as Maintenance Choice and Pharmacy Advisor. We also look for incremental detail on plans to streamline the PBM operations. Taking this into account, we believe the PBM segment should return to high single/low double digit operating profit growth in 2011."JP Morgan maintains its Overweight rating but has raised the price target from $39 to $44.CVS Caremark closed yesterday at $31.43.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorEarningsPrice TargetAnalyst RatingsAetnaConsumer StaplesCVSDrug RetailHealth CareJP MorganManaged Health Carewalgreen